Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People

NCT04844489 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

377

Enrollment

OTHER

Sponsor class

Conditions

Autoimmune or Autoinflammatory Diseases
HIV
Multiple Sclerosis
Solid Tumors or Cancers
Solid Organ Transplant

Interventions

OTHER: Blood samples for the study of the humoral response to SARS-CoV-2 variants and of the cellular response after vaccination against COVID-19

Sponsor

Assistance Publique - Hôpitaux de Paris